Borchman D, Harris E N, Pierangeli S S, Lamba O P
Department of Ophthalmology and Visual Science, Kentucky Lions Eye Research Institute, University of Louisville 40292, USA.
Clin Exp Immunol. 1995 Nov;102(2):373-8. doi: 10.1111/j.1365-2249.1995.tb03792.x.
beta 2-GP1 is a serum protein which influences binding of anticardiolipin antibodies to cardiolipin, may influence induction of these antibodies in animals and may play a role in anticardiolipin-mediated thrombosis. Various investigators have proposed that when beta 2-GP1 binds cardiolipin, structural alterations occur in one or both molecules, resulting in exposure of new epitopes for anticardiolipin binding, but there has been no proof that such alterations occur. Utilizing Fourier transform infrared spectroscopy, this study analysed the structure of cardiolipin and beta 2-GP1 alone, then mixed with each other. For pure cardiolipin, analysis of the CH2 stretching, scissoring and carbonyl bands suggested this molecule assumes a hexagonal crystal lattice packing structure in both anhydrous and aqueous samples. Based on the second derivative analysis of the amide 1 band from the beta 2-GP1 protein backbone, as well as Fourier self-deconvolution and curve fit algorithms, beta 2-GP1 was calculated to contain 18% turns, 37% alpha-helix, and 45% beta-sheet structure. beta 2-GP1 binding with cardiolipin results in a significant change in the conformation as well as geometry of the lipid and protein components. This is indicated by a broadening of the CH stretching band and a marked shift in intensity of the carbonyl band of cardiolipin, indicating less hydrogen bonding. There was a decrease in beta-sheet structure of beta 2-GP1 from 46% to 23% and appearance of 26% to 28% random structure. These findings indicate that mixing beta 2-GP1 with cardiolipin results in profound changes in both molecules which might explain the effect of beta 2-GP1 on anticardiolipin binding activity.
β2 -糖蛋白1是一种血清蛋白,它影响抗心磷脂抗体与心磷脂的结合,可能影响动物体内这些抗体的诱导,并且可能在抗心磷脂介导的血栓形成中起作用。许多研究人员提出,当β2 -糖蛋白1与心磷脂结合时,一个或两个分子会发生结构改变,导致抗心磷脂结合的新表位暴露,但尚无证据表明这种改变会发生。本研究利用傅里叶变换红外光谱分析了单独的心磷脂和β2 -糖蛋白1的结构,然后将它们相互混合。对于纯心磷脂,对CH2伸缩、剪式振动和羰基谱带的分析表明,该分子在无水和水性样品中均呈现六方晶格堆积结构。基于对β2 -糖蛋白1蛋白主链酰胺1谱带的二阶导数分析,以及傅里叶自去卷积和曲线拟合算法,计算得出β2 -糖蛋白1含有18%的转角、37%的α -螺旋和45%的β -折叠结构。β2 -糖蛋白1与心磷脂结合导致脂质和蛋白质成分的构象以及几何形状发生显著变化。这表现为CH伸缩谱带变宽以及心磷脂羰基谱带强度明显位移,表明氢键减少。β2 -糖蛋白1的β -折叠结构从46%降至23%,并出现26%至28%的无规结构。这些发现表明,将β2 -糖蛋白1与心磷脂混合会导致两个分子都发生深刻变化,这可能解释了β2 -糖蛋白1对抗心磷脂结合活性的影响。